EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares gapped down before the market opened on Wednesday . The stock had previously closed at $116.50, but opened at $112.32. EssilorLuxottica shares last traded at $111.0750, with a volume of 20,953 shares traded.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ESLOY. Citigroup reiterated a “buy” rating on shares of EssilorLuxottica in a research note on Thursday, December 11th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Finally, HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Two analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

EssilorLuxottica Price Performance

The firm has a 50 day simple moving average of $135.59 and a two-hundred day simple moving average of $157.35. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.